A simplified, efficient and streamlined workflow for your lab
The BD MAX™ Portfolio of HAI assays are designed to cover a broad suite of HAI solutions. In fact, The BD MAX™ System is a single platform that provides you with the versatility of running BD and partner developed assays, as well as 3rd party and laboratory developed tests. The BD MAX™ System provides your laboratory with key features such as:
Quick results for up to 24 specimens in less than 3 hours*
Quick results can help lower the number of patients developing a HAI or SSI. Studies have found that the use of BD MAX™ StaphSR resulted in a ~5-fold and 10-fold reductions in SSI rates per 100 surgeries vs screening for MRSA-only (direct culture) and no screening, respectively.3
The open-system feature helps broaden testing capabilities
The open-system feature enables extended HAI testing. Screening for extended spectrum beta-lactamase with [Check-Direct] ESBL Screen is possible with the MAX™ system.10
